ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019
Utility of Gonadotropin-Releasing Hormone Agonists for Fertility Preservation: Lack of Biologic Basis and the Need to Prioritize Proven Methods.
Abstract readLetterComment
In one paragraph
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 26 citations in OpenAlex.
- Fertility preservation in 2026: current landscape in Europe and the United States for children and adolescents undergoing hematopoietic stem cell transplantation-recommendations on behalf of the Westhafen Intercontinental Group.Bone marrow transplantation · 2026Review
- Fertility Preservation in 2026: Current Landscape in Europe and the United States for Children and Adolescents Undergoing Hematopoietic Stem Cell Transplantation - Recommendations on Behalf of the Westhafen Intercontinental Group.Transplantation and cellular therapy · 2026Review
- Sex and age disparities in goserelin safety: a global pharmacovigilance study.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- mTOR inhibitors potentially preserve fertility in female patients with haematopoietic malignancies: a narrative review.Annals of hematology · 2024Review
- Fertility Preservation and Ovarian Hyperstimulation Syndrome Management in Cancer Care: A Pathophysiological Perspective on Gonadotropin-Releasing Hormone Agonists and Antagonists.Pathophysiology : the official journal of the International Society for Pathophysiology · 2024Review
- Gonadotropin Releasing Hormone agonist (GnRHa) during chemotherapy and post-cancer childbirths - a Nationwide population-based cohort study of 24,922 women diagnosed with cancer in Sweden.EClinicalMedicine · 2024Article
- Article
- Research progress on the premature ovarian failure caused by cisplatin therapy.Frontiers in oncology · 2023Review
- Ovarian Stem Cells (OSCs) from the Cryopreserved Ovarian Cortex: A Potential for Neo-Oogenesis in Women with Cancer-Treatment Related Infertility: A Case Report and a Review of Literature.Current issues in molecular biology · 2022Review
- Can Some Anticancer Treatments Preserve the Ovarian Reserve?The oncologist · 2021Review
- Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging.Molecular human reproduction · 2020Article
- Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy.Clinical medicine insights. Reproductive health · 2019Review
Corrections and comments
- Commented on by
- Commented on by
- Comment on
- Comment on
Authors and funding
8 authors at 1 institution in 1 country.
Volkan TuranVolkan Turan, Yale University School of Medicine, New Haven, CT, and Yeni Yuzyil University School of Medicine, Istanbul, Turkey; Giuliano Bedoschi, MD, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil; Kenny Rodriguez-Wallberg, MD, PhD, Karolinska Institute and University Hospital, Stockholm, Sweden; Murat Sonmezer, MD, Ankara University School of Medicine, Ankara, Turkey; Fernanda Silva Pacheco, MD, Classiclínica, Porto Alegre, Rio Grande do Sul, Brazil; Ozgur Oktem, MD, Koc University School of Meidcine, Istanbul, Turkey; and Hugh Taylor, MD, and Kutluk Oktay, MD, PhD, Yale University School of Medicine, New Haven, CT.
Giuliano BedoschiVolkan Turan, Yale University School of Medicine, New Haven, CT, and Yeni Yuzyil University School of Medicine, Istanbul, Turkey; Giuliano Bedoschi, MD, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil; Kenny Rodriguez-Wallberg, MD, PhD, Karolinska Institute and University Hospital, Stockholm, Sweden; Murat Sonmezer, MD, Ankara University School of Medicine, Ankara, Turkey; Fernanda Silva Pacheco, MD, Classiclínica, Porto Alegre, Rio Grande do Sul, Brazil; Ozgur Oktem, MD, Koc University School of Meidcine, Istanbul, Turkey; and Hugh Taylor, MD, and Kutluk Oktay, MD, PhD, Yale University School of Medicine, New Haven, CT.
Kenny Rodriguez-WallbergVolkan Turan, Yale University School of Medicine, New Haven, CT, and Yeni Yuzyil University School of Medicine, Istanbul, Turkey; Giuliano Bedoschi, MD, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil; Kenny Rodriguez-Wallberg, MD, PhD, Karolinska Institute and University Hospital, Stockholm, Sweden; Murat Sonmezer, MD, Ankara University School of Medicine, Ankara, Turkey; Fernanda Silva Pacheco, MD, Classiclínica, Porto Alegre, Rio Grande do Sul, Brazil; Ozgur Oktem, MD, Koc University School of Meidcine, Istanbul, Turkey; and Hugh Taylor, MD, and Kutluk Oktay, MD, PhD, Yale University School of Medicine, New Haven, CT.
Murat SonmezerVolkan Turan, Yale University School of Medicine, New Haven, CT, and Yeni Yuzyil University School of Medicine, Istanbul, Turkey; Giuliano Bedoschi, MD, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil; Kenny Rodriguez-Wallberg, MD, PhD, Karolinska Institute and University Hospital, Stockholm, Sweden; Murat Sonmezer, MD, Ankara University School of Medicine, Ankara, Turkey; Fernanda Silva Pacheco, MD, Classiclínica, Porto Alegre, Rio Grande do Sul, Brazil; Ozgur Oktem, MD, Koc University School of Meidcine, Istanbul, Turkey; and Hugh Taylor, MD, and Kutluk Oktay, MD, PhD, Yale University School of Medicine, New Haven, CT.
Fernanda Silva PachecoVolkan Turan, Yale University School of Medicine, New Haven, CT, and Yeni Yuzyil University School of Medicine, Istanbul, Turkey; Giuliano Bedoschi, MD, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil; Kenny Rodriguez-Wallberg, MD, PhD, Karolinska Institute and University Hospital, Stockholm, Sweden; Murat Sonmezer, MD, Ankara University School of Medicine, Ankara, Turkey; Fernanda Silva Pacheco, MD, Classiclínica, Porto Alegre, Rio Grande do Sul, Brazil; Ozgur Oktem, MD, Koc University School of Meidcine, Istanbul, Turkey; and Hugh Taylor, MD, and Kutluk Oktay, MD, PhD, Yale University School of Medicine, New Haven, CT.
Ozgur OktemVolkan Turan, Yale University School of Medicine, New Haven, CT, and Yeni Yuzyil University School of Medicine, Istanbul, Turkey; Giuliano Bedoschi, MD, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil; Kenny Rodriguez-Wallberg, MD, PhD, Karolinska Institute and University Hospital, Stockholm, Sweden; Murat Sonmezer, MD, Ankara University School of Medicine, Ankara, Turkey; Fernanda Silva Pacheco, MD, Classiclínica, Porto Alegre, Rio Grande do Sul, Brazil; Ozgur Oktem, MD, Koc University School of Meidcine, Istanbul, Turkey; and Hugh Taylor, MD, and Kutluk Oktay, MD, PhD, Yale University School of Medicine, New Haven, CT.
Hugh TaylorVolkan Turan, Yale University School of Medicine, New Haven, CT, and Yeni Yuzyil University School of Medicine, Istanbul, Turkey; Giuliano Bedoschi, MD, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil; Kenny Rodriguez-Wallberg, MD, PhD, Karolinska Institute and University Hospital, Stockholm, Sweden; Murat Sonmezer, MD, Ankara University School of Medicine, Ankara, Turkey; Fernanda Silva Pacheco, MD, Classiclínica, Porto Alegre, Rio Grande do Sul, Brazil; Ozgur Oktem, MD, Koc University School of Meidcine, Istanbul, Turkey; and Hugh Taylor, MD, and Kutluk Oktay, MD, PhD, Yale University School of Medicine, New Haven, CT.
Kutluk OktayVolkan Turan, Yale University School of Medicine, New Haven, CT, and Yeni Yuzyil University School of Medicine, Istanbul, Turkey; Giuliano Bedoschi, MD, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil; Kenny Rodriguez-Wallberg, MD, PhD, Karolinska Institute and University Hospital, Stockholm, Sweden; Murat Sonmezer, MD, Ankara University School of Medicine, Ankara, Turkey; Fernanda Silva Pacheco, MD, Classiclínica, Porto Alegre, Rio Grande do Sul, Brazil; Ozgur Oktem, MD, Koc University School of Meidcine, Istanbul, Turkey; and Hugh Taylor, MD, and Kutluk Oktay, MD, PhD, Yale University School of Medicine, New Haven, CT.
Istanbul Yeni Yüzyıl University · TR
Funding
Characterization & Prevention of Chemotherapy-Induced Damage to Ovarian ReserveR01HD053112 · NICHD · YALE UNIVERSITY · PI KUTLUK H OKTAY · 2007 to 2026
$7.6MNICHD NIH HHS R01 HD053112
Abstract
PubMed holds no abstract for this paper.
Indexed as
Biological ProductsBreast NeoplasmsFertility PreservationFertilityGonadotropin-Releasing HormoneHumansBiological ProductsGonadotropin-Releasing Hormone
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.